Iran Press/Iran News: It is said that 300 volunteers in the second phase and 20,000 volunteers in the third phase will get the vaccine jab.
The results of the first phase of the vaccine's human trial were promising.
In the first phase, 56 volunteers between 18 to 50 years old had received two doses of the vaccine.
214/216
Read more:
Results of 1st phase of COVIran Barekat vaccine announced
COV-Iran Barekat vaccine 97% effective: Official
